KP Tissue Valuation
| KPT Stock | CAD 10.45 0.22 2.15% |
At this time, the firm appears to be undervalued. KP Tissue owns a latest Real Value of C$11.55 per share. The recent price of the firm is C$10.45. Our model forecasts the value of KP Tissue from analyzing the firm fundamentals such as EBITDA of 264.78 M, shares outstanding of 10.01 M, and Current Valuation of 104.59 M as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting KP Tissue's valuation include:
Undervalued
Today
Please note that KP Tissue's price fluctuation is very steady at this time. Calculation of the real value of KP Tissue is based on 3 months time horizon. Increasing KP Tissue's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since KP Tissue is currently traded on the exchange, buyers and sellers on that exchange determine the market value of KPT Stock. However, KP Tissue's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 10.45 | Real 11.55 | Hype 10.44 | Naive 10.19 |
The intrinsic value of KP Tissue's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence KP Tissue's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of KP Tissue helps investors to forecast how KPT stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of KP Tissue more accurately as focusing exclusively on KP Tissue's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use KP Tissue's intrinsic value based on its ongoing forecasts of KP Tissue's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against KP Tissue's closest peers.
KP Tissue Total Value Analysis
KP Tissue is now anticipated to have takeover price of 104.59 M with market capitalization of 104.59 M, debt of 1.8 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the KP Tissue fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
104.59 M | 104.59 M | 1.8 M |
KP Tissue Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The recent return on assets of KPT suggests not a very effective usage of assets in December.KP Tissue Ownership Allocation
The market capitalization of KP Tissue is C$104.59 Million. Around 91.32 % of KP Tissue outstanding shares are held by general public with 0.47 percent owned by insiders and only 8.21 (percent) by institutions. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the firm is less than the current market value, you may not be able generate positive returns on investment in the long run.KP Tissue Profitability Analysis
Net Income was 2.43 M with profit before overhead, payroll, taxes, and interest of 0.KP Tissue Past Distributions to stockholders
About KP Tissue Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of KP Tissue. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of KP Tissue based exclusively on its fundamental and basic technical indicators. By analyzing KP Tissue's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of KP Tissue's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of KP Tissue. We calculate exposure to KP Tissue's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of KP Tissue's related companies.| Last Reported | Projected for Next Year | ||
| Net Loss | (29.56) | (28.08) |
Other Information on Investing in KPT Stock
KP Tissue financial ratios help investors to determine whether KPT Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in KPT with respect to the benefits of owning KP Tissue security.